(Q68366872)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2123133%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

title

Comparison of the pharmacokinetics and pharmacodynamics of unformulated and formulated 4-hydroxyandrostenedione taken orally by healthy men (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2123133%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference

1 reference

M Dowsett

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2123133%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

P Lloyd

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2123133%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

publication date

1 January 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2123133%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

23 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2123133%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2123133%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2123133%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

67-71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2123133%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference

12 December 2020

Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer

1 reference

12 December 2020

4-Hydroxyandrostenedione treatment for postmenopausal patients with advanced breast cancer

1 reference

12 December 2020

Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancer

1 reference

12 December 2020

4-Hydroxyandrostenedione in treatment of postmenopausal patients with advanced breast cancer

1 reference

12 December 2020

Metabolism of the aromatase inhibitor 4-hydroxyandrostenedione in vivo. Identification of the glucuronide as a major urinary metabolite in patients and biliary metabolite in the rat.

1 reference

12 December 2020

A standardised multicentre procedure for plasma gonadotrophin radioimmunoassay

1 reference

12 December 2020

Short- and Long-Term Effects of Clomiphene Citrate on the Pituitary-Testicular Axis

1 reference

12 December 2020

Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report

1 reference

12 December 2020

Oral 4-hydroxyandrostenedione, a new endocrine treatment for disseminated breast cancer

1 reference

12 December 2020

1 reference

12 December 2020

Inhibition of aromatization stimulates luteinizing hormone and testosterone secretion in adult male rhesus monkeys

1 reference

12 December 2020

Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route

1 reference

12 December 2020

Endocrine and Therapeutic Effects of Aminoglutethimide in Premenopausal Patients with Breast Cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00689279

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2123133%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference